Evidence map›Paper›PMID 33460744›Full record

ArticleComplementary therapies in medicine2021

Mixed methods study of the potential therapeutic benefits from medical cannabis for patients in Florida.

John S Luque, Arinze Nkemdirim Okere, Carlos A Reyes-Ortiz, Paula M Williams

Open access · goldAbstract read
In one paragraph

Article in Complementary therapies in medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
3.6field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Article
  3. Experiences and Comfort of Young Cancer Patients Discussing Cannabis with Their Providers: Insights from a Survey at an NCI-Designated Cancer Center.Journal of cancer education : the official journal of the American Association for Cancer Education · 2025
    Article
  4. Article
  5. Discussions on Medical Cannabis: Addressing Missed Opportunities in Cancer Education.Journal of cancer education : the official journal of the American Association for Cancer Education · 2024
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Perceived Stigma of Patients Undergoing Treatment with Cannabis-Based Medicinal Products.International journal of environmental research and public health · 2022
    Article
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

John S LuqueCollege of Pharmacy & Pharmaceutical Sciences, Institute of Public Health, Florida A&M University, United States. Electronic address: john.luque@famu.edu.
Arinze Nkemdirim OkereCollege of Pharmacy & Pharmaceutical Sciences, Institute of Public Health, Florida A&M University, United States.
Carlos A Reyes-OrtizCollege of Pharmacy & Pharmaceutical Sciences, Institute of Public Health, Florida A&M University, United States.
Paula M WilliamsCollege of Pharmacy & Pharmaceutical Sciences, Institute of Public Health, Florida A&M University, United States.
Florida Agricultural and Mechanical University · US

Funding

Research Project-3: Effectiveness of an eHealth intervention for uptake of cervical cancer screening in Hispanic womenU54MD007582 · NIMHD · FLORIDA AGRICULTURAL AND MECHANICAL UNIV · PI Sandra G Suther · 2019 to 2026
$28.1M
NIMHD NIH HHS U54 MD007582
6 · The paper itself

Abstract

objectivesTo evaluate medical marijuana patients' perceptions of therapeutic benefits for self-reported medical conditions.

designThe study was a concurrent mixed methods study with adult medical marijuana patients. Survey data were collected using a web-based survey, and interviews were conducted in person or over the phone.

settingThe study recruited 196 medical marijuana patients to complete surveys and 13 patients to participate in qualitative interviews in Florida. MEASURES: A validated patient survey was distributed via Florida medical marijuana social media groups to examine the therapeutic benefits of the cannabis plant for medical conditions and overall well-being. Concurrently, qualitative interviews were conducted to understand barriers and facilitators to accessing medical cannabis and explore preferences for different forms and strains, as well as any unexpected side effects.

resultsPatients used medical cannabis for relief of chronic pain or depression, followed by arthritis and nausea. Survey results indicated 89 % of patients reported "great relief" for their medical condition. Over 76 % of patients reported a score of 8 or higher on a 10-point scale that their medical condition had improved, and over 68 % reported a score of 8 or higher that medical cannabis had reduced their pain. Interviews indicated medical cannabis was effective for pain relief and reducing the use of prescription medicines, but the drug was perceived as too expensive.

conclusionsMedical marijuana patients were positive about the health benefits they received and the fact they were able to reduce or eliminate many prescription medications; however, there were concerns about the costs.

Indexed as

CannabisChronic PainMedical MarijuanaAdultFloridaHumansNauseaMedical MarijuanaAnalgesicsCannabisMedical marijuanaPain management

Identifiers

PMID33460744
PMCPMC8053674
OpenAlexW3120372938

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.